FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2012912392> ?p ?o ?g. }

• W2012912392 endingPage "113" @default.
• W2012912392 startingPage "108" @default.
• W2012912392 abstract "Oxaliplatin is a platinum analog and radiosensitizer active in colorectal cancer. We performed a Phase I trial to test the safety and preliminary efficacy of adding oxaliplatin to standard preoperative chemoradiation therapy for rectal cancer.Eligible patients had T3 to T4 rectal adenocarcinoma. Patients received standard-dose radiation (50.4 Gy for 5.5 weeks) with concurrent infused 5-fluorouracil (5-FU) at 200 mg/m2 per day, 7 days per week. Oxaliplatin was given three times at 14-day intervals at 55, 70, or 85 mg/m2 during the 5.5-week radiation period, before resection. Adjuvant therapy consisted of four cycles of 5-FU (500 mg/m2 per week) with leucovorin (500 mg/m2 per week) given every 6 weeks. The main goals were to identify the maximum tolerated dose of oxaliplatin and the dose-limiting toxicities when given with 5-FU and RT. Secondary goals were to determine resectability, pathologic response, sphincter preservation, and overall survival rates.Twenty-one patients were enrolled, 5 at the 55 mg/m2 oxaliplatin dose level, 5 at 70 mg/m2, and 11 at 85 mg/m2. All patients were able to complete the preoperative chemoradiation regimen with no dose adjustments. No dose-limiting toxicities or differences in the type or extent of toxicity were noted among the groups. Nineteen patients underwent surgery (three abdominopelvic resections and 16 low anterior resections), for an 84% sphincter preservation rate. The pathologic complete response rate was 26% (5 patients), and minimal microscopic residual tumor was found in 21% (4 additional patients).Oxaliplatin was well tolerated at 85 mg/m2 given every 2 weeks in combination with standard preoperative chemoradiation for rectal cancer. The rates of major pathologic response and sphincter preservation are promising." @default.
• W2012912392 created "2016-06-24" @default.
• W2012912392 creator A5006604886 @default.
• W2012912392 creator A5029706633 @default.
• W2012912392 creator A5031110316 @default.
• W2012912392 creator A5031390646 @default.
• W2012912392 creator A5065088834 @default.
• W2012912392 creator A5069129452 @default.
• W2012912392 creator A5080675098 @default.
• W2012912392 date "2008-09-01" @default.
• W2012912392 modified "2023-09-27" @default.
• W2012912392 title "Phase I Study of Preoperative Radiation Therapy With Concurrent Infusional 5-Fluorouracil and Oxaliplatin Followed by Surgery and Postoperative 5-Fluorouracil Plus Leucovorin for T3/T4 Rectal Adenocarcinoma: ECOG E1297" @default.
• W2012912392 cites W1540960632 @default.
• W2012912392 cites W1976508366 @default.
• W2012912392 cites W1994527599 @default.
• W2012912392 cites W2022848495 @default.
• W2012912392 cites W2031210616 @default.
• W2012912392 cites W2033465919 @default.
• W2012912392 cites W2037673809 @default.
• W2012912392 cites W2072729991 @default.
• W2012912392 cites W2093264449 @default.
• W2012912392 cites W2098803991 @default.
• W2012912392 cites W2117500868 @default.
• W2012912392 cites W2121761389 @default.
• W2012912392 cites W2124695217 @default.
• W2012912392 cites W2125452425 @default.
• W2012912392 cites W2128941960 @default.
• W2012912392 cites W2132565869 @default.
• W2012912392 cites W2133399075 @default.
• W2012912392 cites W2141363209 @default.
• W2012912392 cites W2143655828 @default.
• W2012912392 cites W2143769865 @default.
• W2012912392 cites W2168323176 @default.
• W2012912392 cites W4233200910 @default.
• W2012912392 doi "https://doi.org/10.1016/j.ijrobp.2008.05.054" @default.
• W2012912392 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/4198328" @default.
• W2012912392 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/18722265" @default.
• W2012912392 hasPublicationYear "2008" @default.
• W2012912392 type Work @default.
• W2012912392 sameAs 2012912392 @default.
• W2012912392 citedByCount "27" @default.
• W2012912392 countsByYear W20129123922012 @default.
• W2012912392 countsByYear W20129123922013 @default.
• W2012912392 countsByYear W20129123922014 @default.
• W2012912392 countsByYear W20129123922015 @default.
• W2012912392 countsByYear W20129123922016 @default.
• W2012912392 countsByYear W20129123922018 @default.
• W2012912392 countsByYear W20129123922019 @default.
• W2012912392 countsByYear W20129123922021 @default.
• W2012912392 countsByYear W20129123922023 @default.
• W2012912392 crossrefType "journal-article" @default.
• W2012912392 hasAuthorship W2012912392A5006604886 @default.
• W2012912392 hasAuthorship W2012912392A5029706633 @default.
• W2012912392 hasAuthorship W2012912392A5031110316 @default.
• W2012912392 hasAuthorship W2012912392A5031390646 @default.
• W2012912392 hasAuthorship W2012912392A5065088834 @default.
• W2012912392 hasAuthorship W2012912392A5069129452 @default.
• W2012912392 hasAuthorship W2012912392A5080675098 @default.
• W2012912392 hasBestOaLocation W20129123922 @default.
• W2012912392 hasConcept C121608353 @default.
• W2012912392 hasConcept C126322002 @default.
• W2012912392 hasConcept C141071460 @default.
• W2012912392 hasConcept C2776694085 @default.
• W2012912392 hasConcept C2778424827 @default.
• W2012912392 hasConcept C2780456651 @default.
• W2012912392 hasConcept C2780962732 @default.
• W2012912392 hasConcept C2781413609 @default.
• W2012912392 hasConcept C509974204 @default.
• W2012912392 hasConcept C526805850 @default.
• W2012912392 hasConcept C71924100 @default.
• W2012912392 hasConcept C90924648 @default.
• W2012912392 hasConceptScore W2012912392C121608353 @default.
• W2012912392 hasConceptScore W2012912392C126322002 @default.
• W2012912392 hasConceptScore W2012912392C141071460 @default.
• W2012912392 hasConceptScore W2012912392C2776694085 @default.
• W2012912392 hasConceptScore W2012912392C2778424827 @default.
• W2012912392 hasConceptScore W2012912392C2780456651 @default.
• W2012912392 hasConceptScore W2012912392C2780962732 @default.
• W2012912392 hasConceptScore W2012912392C2781413609 @default.
• W2012912392 hasConceptScore W2012912392C509974204 @default.
• W2012912392 hasConceptScore W2012912392C526805850 @default.
• W2012912392 hasConceptScore W2012912392C71924100 @default.
• W2012912392 hasConceptScore W2012912392C90924648 @default.
• W2012912392 hasIssue "1" @default.
• W2012912392 hasLocation W20129123921 @default.
• W2012912392 hasLocation W20129123922 @default.
• W2012912392 hasLocation W20129123923 @default.
• W2012912392 hasLocation W20129123924 @default.
• W2012912392 hasOpenAccess W2012912392 @default.
• W2012912392 hasPrimaryLocation W20129123921 @default.
• W2012912392 hasRelatedWork W1965462694 @default.
• W2012912392 hasRelatedWork W2105427184 @default.
• W2012912392 hasRelatedWork W2328865574 @default.
• W2012912392 hasRelatedWork W2360239665 @default.
• W2012912392 hasRelatedWork W2368410016 @default.
• W2012912392 hasRelatedWork W2375079248 @default.
• W2012912392 hasRelatedWork W2376526608 @default.
• W2012912392 hasRelatedWork W3031442329 @default.

• next